Nuclear Radiology: Page 40

TOF PET improves cancer detection
By AuntMinnie.com staff writers
For the first time, quantitative, rather than qualitative, data analysis has demonstrated that time-of-flight (TOF) PET scans can improve cancer detection, according to a new study in the March issue of the Journal of Nuclear Medicine.
March 2, 2011
UltraSPECT gets FDA OK for PET application
By AuntMinnie.com staff writers
Nuclear medicine firm UltraSPECT said it has received clearance from the U.S. Food and Drug Administration for its whole-body PET imaging reconstruction application.
March 1, 2011
Naviscan inks licensing deal with Neoprobe
By AuntMinnie.com staff writers
PET developer Naviscan has signed an exclusive licensing agreement with gamma camera probe developer Neoprobe to further develop Naviscan's patented imaging technology.
February 24, 2011
GE completes Orbotech acquisition
By AuntMinnie.com staff writers
GE Healthcare has completed its acquisition of Orbotech Medical Solutions, a manufacturer of cadmium zinc telluride detectors used in GE Healthcare's Alcyone nuclear medicine technology.
February 16, 2011
Neoprobe reaches clinical study goal
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe said it has enrolled enough clinical subjects to achieve its minimum goal for a multicenter phase III study of its Lymphoseek radiotracer.
February 14, 2011
Neoprobe to list stock on NYSE Amex
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe's common stock is moving to the New York Stock Exchange (NYSE) Amex exchange.
February 7, 2011
PET may predict response to targeted therapy of thyroid cancer
By Wayne Forrest
Swiss researchers have found evidence that PET imaging may detect metabolic changes following treatment with the protein kinase inhibitor vandetanib, and help in the evaluation of therapy response, according to a study in the February issue of the Journal of Nuclear Medicine.
February 1, 2011
2011 02 01 17 44 56 605 Vandetanib Image Thumb
Gamma camera market to hit $820M by 2015
By AuntMinnie.com staff writers
The global market for gamma cameras is projected to produce $820 million in revenue by 2015, according to a new market research report by Global Industry Analysts.
January 25, 2011
Neoprobe schedules FDA meeting
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe will meet with the U.S. Food and Drug Administration in the first quarter of 2010 to discuss its plans to begin clinical testing of its RIGScan cancer-detecting technology.
December 9, 2010
GammaLoc adds to Dilon gamma cameras
By AuntMinnie.com staff writers
Breast-specific gamma imaging developer Dilon Diagnostics' GammaLoc gamma-guided biopsy system is being implemented as an accessory to Dilon 6800 gamma cameras in North and Central America, Europe, the Middle East, and Asia.
November 22, 2010
IBA Molecular acquires PETLinQ
By AuntMinnie.com staff writers
Radiopharmaceutical developer IBA Molecular has acquired PETLinQ, an education and software company serving the hospital, outpatient radiology, PET, and nuclear medicine markets.
November 2, 2010
Neoprobe scores grant
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe has received a $244,000 grant from the U.S. Department of Health and Human Services.
November 2, 2010
Previous Page
Page 40 of 81
Next Page